Evaluating Safety and Effectiveness of Alemtuzumab in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Previously Treated with Natalizumab: A Real World Experience.
Phase of Trial: Phase IV
Latest Information Update: 20 Nov 2016
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 20 Nov 2016 New trial record